NCT05934071: Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF. |
|
|
| Recruiting | N/A | 160 | Europe | SGLT2 inhibitor, Dapaglifozin, Empaglifozin | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Heart Failure, Ventricular Remodeling, Ventricular Dysfunction | 12/24 | 12/24 | | |